Artificial Intelligence in Endoscopic Ultrasound
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorOrlando Health, Inc.
About this trial
The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Any patient undergoing endoscopic ultrasound examination
Disqualifiers
Age < 18 years
Trial design
Treatments tested in this trial
- Patients undergoing endoscopic ultrasound procedures
Treatment groups
310 Participants
are divided into 1 treatment groupLocations
1Orlando Health32806, OrlandoFlorida, United States
Sponsors and collaborators
Orlando Health, Inc.
Lead sponsor
Source ClinicalTrials.gov